These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18632709)

  • 1. Key opinion leaders: How to spot one.
    Spiers AS
    BMJ; 2008 Jul; 337(7662):a790. PubMed ID: 18632709
    [No Abstract]   [Full Text] [Related]  

  • 2. Key opinion leaders: used as a marketing tool by drug companies.
    Prescrire Int; 2012 Jun; 21(128):163-5. PubMed ID: 22822596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should the drug industry work with key opinion leaders? Yes.
    Buckwell C
    BMJ; 2008 Jun; 336(7658):1404. PubMed ID: 18566075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should the drug industry work with key opinion leaders? No.
    Fava GA
    BMJ; 2008 Jun; 336(7658):1405. PubMed ID: 18566076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building legitimacy by criticising the pharmaceutical industry: a qualitative study among prescribers and local opinion leaders.
    Pittet AL; Saraga M; Stiefel F
    Swiss Med Wkly; 2015; 145():w14240. PubMed ID: 26661626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key opinion leaders: Thus are our medical meetings managed.
    Fugh-Berman A
    BMJ; 2008 Jul; 337(7662):a789. PubMed ID: 18632708
    [No Abstract]   [Full Text] [Related]  

  • 7. Kissing goodbye to key opinion leaders.
    Moynihan RN
    Med J Aust; 2012 Jun; 196(11):671. PubMed ID: 22708752
    [No Abstract]   [Full Text] [Related]  

  • 8. Key opinion leaders: independent experts or drug representatives in disguise?
    Moynihan R
    BMJ; 2008 Jun; 336(7658):1402-3. PubMed ID: 18566074
    [No Abstract]   [Full Text] [Related]  

  • 9. New image for the drug industry.
    Cohen D
    BMJ; 2011 Nov; 343():d7713. PubMed ID: 22127772
    [No Abstract]   [Full Text] [Related]  

  • 10. Public Relations: Ketchum brands new product with innovative PR strategy.
    Profiles Healthc Commun; 2006; 22(5):11-4, 2. PubMed ID: 17048759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Big pharma under the spotlight.
    Farham B
    S Afr Med J; 2013 May; 103(6):352. PubMed ID: 23725968
    [No Abstract]   [Full Text] [Related]  

  • 12. Andrew Witty: the acceptable face of big pharma? Interviewed by Rebecca Coombes.
    Witty A
    BMJ; 2013 Mar; 346():f1458. PubMed ID: 23468295
    [No Abstract]   [Full Text] [Related]  

  • 13. Spin cycles. Healthcare marketing-communications efforts have taken on increasing strategic importance.
    Romano M
    Mod Healthc; 2005 Nov; 35(47):28-30. PubMed ID: 16334365
    [No Abstract]   [Full Text] [Related]  

  • 14. Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on.
    Sismondo S
    J Law Med Ethics; 2013; 41(3):635-43. PubMed ID: 24088154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug industry told to disclose details of doctors' events.
    Burton B
    BMJ; 2006 Aug; 333(7562):278. PubMed ID: 16888302
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of the pharmaceutical industry in medicine.
    Jelinek GA; Neate SL
    J Law Med; 2009 Oct; 17(2):216-23. PubMed ID: 19998591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syphilis and Pharmaceutical Industry Marketing Between the Two World Wars in Croatia.
    Fatović-Ferenčić S; Kuhar M
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):14-23. PubMed ID: 32650846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reining in the sales reps. PinnacleHealth protects patients and their privacy with a supplier relations program.
    Tambolas S
    Health Forum J; 2002; 45(6):50-1. PubMed ID: 12506794
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug industry is now biggest defrauder of US government.
    Braillon A
    BMJ; 2012 Jan; 344():d8219. PubMed ID: 22235007
    [No Abstract]   [Full Text] [Related]  

  • 20. Key opinion leaders: where they come from and how that affects the drugs you prescribe.
    Meffert JJ
    Dermatol Ther; 2009; 22(3):262-8. PubMed ID: 19453351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.